fromIPWatchdog.com | Patents & Intellectual Property Law
6 months agoIntellectual property law
Life Sciences Masters Panelists Say USPTO's Controversial Anti-Pharma Rules are Unlikely to Progress
The pharmaceutical industry faces significant scrutiny, yet recent proposals damaging to it are unlikely to advance.